The Emerging Infectious Disease (EID) market is a subset of the Infectious Disease Testing market. It focuses on the detection and diagnosis of new or re-emerging infectious diseases, such as those caused by bacteria, viruses, fungi, and parasites. EID testing is used to identify and monitor the spread of these diseases, as well as to develop treatments and vaccines. EID testing is typically conducted in laboratories, using a variety of methods, such as PCR, ELISA, and sequencing. EID testing is becoming increasingly important as new and re-emerging infectious diseases continue to emerge. It is used to detect and monitor the spread of these diseases, as well as to develop treatments and vaccines. As such, the EID market is expected to grow in the coming years. Some companies in the EID market include Abbott, Becton Dickinson, Cepheid, Hologic, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
